Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Rapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma.

Deulofeu M, Kolářová L, Salvadó V, María Peña-Méndez E, Almáši M, Štork M, Pour L, Boadas-Vaello P, Ševčíková S, Havel J, Vaňhara P.

Sci Rep. 2019 May 28;9(1):7975. doi: 10.1038/s41598-019-44215-1.

2.

Extramedullary disease in multiple myeloma - controversies and future directions.

Sevcikova S, Minarik J, Stork M, Jelinek T, Pour L, Hajek R.

Blood Rev. 2019 Jul;36:32-39. doi: 10.1016/j.blre.2019.04.002. Epub 2019 Apr 13. Review.

3.

Long Non-Coding RNAs in Multiple Myeloma.

Butova R, Vychytilova-Faltejskova P, Souckova A, Sevcikova S, Hajek R.

Noncoding RNA. 2019 Jan 24;5(1). pii: E13. doi: 10.3390/ncrna5010013. Review.

4.

Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).

Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K.

Klin Onkol. Summer 2018;31(4):270-276. doi: 10.14735/amko2018270.

PMID:
30541309
5.

The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma.

Vrábel D, Pour L, Ševčíková S.

Blood Rev. 2019 Mar;34:56-66. doi: 10.1016/j.blre.2018.11.003. Epub 2018 Nov 23. Review.

6.

Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients.

Almasi M, Besse L, Brozova L, Jarkovsky J, Bezdekova R, Pour L, Minarik J, Kessler P, Pavlíček P, Roziakova L, Penka M, Hájek R, Vasku A, Sevcikova S.

Klin Onkol. Spring 2018;31(3):213-229. doi: 10.14735/amko2018213.

PMID:
30441975
7.

The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple Myeloma.

Steiner N, Hajek R, Sevcikova S, Borjan B, Untergasser G, Göbel G, Gunsilius E.

Anticancer Res. 2018 Sep;38(9):5087-5092. doi: 10.21873/anticanres.12828.

PMID:
30194153
8.

Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies.

Sedlarikova L, Bollova B, Radova L, Brozova L, Jarkovsky J, Almasi M, Penka M, Kuglík P, Sandecká V, Stork M, Pour L, Sevcikova S.

Hematol Oncol. 2018 Dec;36(5):786-791. doi: 10.1002/hon.2554. Epub 2018 Sep 13.

9.

The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets.

Steiner N, Müller U, Hajek R, Sevcikova S, Borjan B, Jöhrer K, Göbel G, Pircher A, Gunsilius E.

PLoS One. 2018 Aug 10;13(8):e0202045. doi: 10.1371/journal.pone.0202045. eCollection 2018.

10.

High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.

Steiner N, Hajek R, Sevcikova S, Borjan B, Jöhrer K, Göbel G, Untergasser G, Gunsilius E.

PLoS One. 2017 Jul 20;12(7):e0181487. doi: 10.1371/journal.pone.0181487. eCollection 2017.

11.

Cell-free DNA - Minimally invasive marker of hematological malignancies.

Kubaczkova V, Vrabel D, Sedlarikova L, Besse L, Sevcikova S.

Eur J Haematol. 2017 Oct;99(4):291-299. doi: 10.1111/ejh.12925. Epub 2017 Aug 3. Review.

PMID:
28692178
12.

Deregulated expression of long non-coding RNA UCA1 in multiple myeloma.

Sedlarikova L, Gromesova B, Kubaczkova V, Radova L, Filipova J, Jarkovsky J, Brozova L, Velichova R, Almasi M, Penka M, Bezdekova R, Stork M, Adam Z, Pour L, Krejci M, Kuglík P, Hajek R, Sevcikova S.

Eur J Haematol. 2017 Sep;99(3):223-233. doi: 10.1111/ejh.12908. Epub 2017 Jun 29.

PMID:
28543758
13.

A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.

Sandecká V, Hájek R, Pour L, Špička I, Ščudla V, Gregora E, Radocha J, Walterová L, Kessler P, Zahradová L, Adamová D, Valentova K, Vonke I, Obernauerová J, Starostka D, Wróbel M, Brožová L, Jarkovský J, Mikulášová A, Říhová L, Ševčíková S, Straub J, Minařík J, Adam Z, Krejčí M, Král Z, Maisnar V; Czech Myeloma Group.

Eur J Haematol. 2017 Jul;99(1):80-90. doi: 10.1111/ejh.12894. Epub 2017 May 11.

PMID:
28384387
14.

[Pomalidomide in the treatment of multiple myeloma - own experience and overview of literature].

Adam Z, Pour L, Krejčí M, Vetešníková E, Sandecká V, Štork M, Čermáková Z, Pourová E, Ševčíková S, Král Z, Mayer J.

Vnitr Lek. Winter 2016;62(12):962-968. Review. Czech.

PMID:
28139124
15.

[Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].

Adam Z, Petrášová H, Řehák Z, Koukalová R, Krejčí M, Pour L, Vetešníková E, Čermák A, Ševčíková S, Szturz P, Král Z, Mayer J.

Vnitr Lek. Fall 2016;62(10):820-832. Review. Czech.

PMID:
27900869
16.

[Schnitzlers SyndromeDifferential diagnostics, an overview of therapeutic options and description of 5 cases treated with anakinra].

Adam Z, Šedivá A, Koukalová R, Řehák Z, Petrášová H, Szturz P, Adamová Z, Vetešníková E, Pour L, Krejčí M, Sandecká V, Pourová E, Čermáková Z, Ševčíková S, Král Z, Mayer J.

Vnitr Lek. Fall 2016;62(9):713-727. Review. Czech.

PMID:
27715073
17.

[Hypercalcemia, symptoms, differential diagnostics and treatment, or importance of calcium investigation].

Adam Z, Starý K, Kubinyi J, Zajíčková K, Řehák Z, Koukalová R, Tomíška M, Doubková M, Prášek J, Pourová E, Čermáková Z, Pour L, Krejčí M, Sandecká V, Ševčíková E, Ševčíková S, Král Z, Čermák A.

Vnitr Lek. Spring 2016;62(5):370-83. Czech.

PMID:
27319230
18.

[Treatment of 14 cases of Castlemans disease: the experience of one centre and an overview of literature].

Adam Z, Szturz P, Krejčí M, Koukalová R, Michalková E, Řehák Z, Pourová E, Pour L, Volfová P, Sandecká V, Čermáková Z, Křen L, Sokol F, Hanke I, Penka I, Petrášová H, Ševčíková S, Král Z, Mayer J.

Vnitr Lek. 2016 Apr;62(4):287-98. Review. Czech.

PMID:
27250606
19.

[The patient complains of spinal pain or fatigue and weakness. How do I recognize whether their cause is spondylarthrosis, the patients age or multiple myeloma?].

Adam Z, Pourová E, Pour L, Michalková E, Krejčí M, Koukalová R, Řehák Z, Vaníček J, Nebeský T, Petrášová H, Ševčíková S, Mašek M, Král Z, Čermák A.

Vnitr Lek. 2016 Feb;62(2):114-24. Czech.

PMID:
27172438
20.

[Gene mutations connected to Waldenstöm macroglobulinemia].

Kutálková K, Sedlaříková L, Adam Z, Ševčíková S.

Vnitr Lek. 2016 Jan;62(1):40-3. Review. Czech.

PMID:
26967235

Supplemental Content

Loading ...
Support Center